Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinho Shin

Showing results (221-230 of 279) with videos related to

Pageof 28
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2020
The feasibility of polypill for cardiovascular disease prevention in Asian PopulationApichard Sukonthasarn, Yook-Chin Chia, Ji-Guang Wang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Regional differences in office and self-measured home heart rates in Asian hypertensive patients: AsiaBP@Home studyNaoko Tomitani, Satoshi Hoshide, Peera Buranakitjaroen, et al.
The Korean Journal of Internal Medicine|June 12, 2017
Diagnostic accuracy of manual office blood pressure measurement in ambulatory hypertensive patients in KoreaSehun Kim, Jin Joo Park, Seung-Ah Lee, et al.
Clinical Hypertension|January 26, 2021
Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of HypertensionHae Young Lee, Dong-Ju Lee, Jongmo Seo, et al.
Clinical Therapeutics|October 29, 2025
Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionJinho Shin, SeongHwan Kim, KiHoon Han, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 19, 2019
Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia NetworkKazuomi Kario, Jinho Shin, Chen-Huan Chen, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2017
Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regionsKazuomi Kario, Naoko Tomitani, Peera Buranakitjaroen, et al.
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Discrepancies between home blood pressure and ambulatory blood pressure monitoring in apparent treatment-resistant hypertension: analysis from the Korean resistant hypertension cohortJiwon Seo, Chan Joo Lee, Dae-Hee Kim, et al.
Pageof 28

Showing results (221-230 of 279) with videos related to

Sort By:
Pageof 28
Journal of Clinical Hypertension (Greenwich, Conn.)|October 21, 2020
The feasibility of polypill for cardiovascular disease prevention in Asian PopulationApichard Sukonthasarn, Yook-Chin Chia, Ji-Guang Wang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2021
Regional differences in office and self-measured home heart rates in Asian hypertensive patients: AsiaBP@Home studyNaoko Tomitani, Satoshi Hoshide, Peera Buranakitjaroen, et al.
The Korean Journal of Internal Medicine|June 12, 2017
Diagnostic accuracy of manual office blood pressure measurement in ambulatory hypertensive patients in KoreaSehun Kim, Jin Joo Park, Seung-Ah Lee, et al.
Clinical Hypertension|January 26, 2021
Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of HypertensionHae Young Lee, Dong-Ju Lee, Jongmo Seo, et al.
Clinical Therapeutics|October 29, 2025
Multicenter, Randomized, Double-Blind, Parallel, Phase 2 Clinical Trial to Compare and Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionJinho Shin, SeongHwan Kim, KiHoon Han, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 19, 2019
Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: The HOPE Asia NetworkKazuomi Kario, Jinho Shin, Chen-Huan Chen, et al.
JAMA|May 14, 2025
Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical TrialChan Joo Lee, Sang-Hyun Ihm, Dong-Ho Shin, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|December 22, 2017
Rationale and design for the Asia BP@Home study on home blood pressure control status in 12 Asian countries and regionsKazuomi Kario, Naoko Tomitani, Peera Buranakitjaroen, et al.
Clinical Hypertension|December 1, 2022
A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapyEun-Seok Jeon, Sang Wook Lim, Seok-Yeon Kim, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 15, 2024
Discrepancies between home blood pressure and ambulatory blood pressure monitoring in apparent treatment-resistant hypertension: analysis from the Korean resistant hypertension cohortJiwon Seo, Chan Joo Lee, Dae-Hee Kim, et al.
Pageof 28